Have you had a heart attack after being on dialysis using GranuFlo or NatruaLyte?

You may be entitled to a CASH SETTLEMENT

Use of GranuFlo and NatruaLyte during dialysis linked to heart attacks

Manufactured by the German medical care company, Fresenius; NaturaLyte Liquid Acid Concentrate and GranuFlo Powderized Acid Concentrate, are dialysates that were being used during kidney dialysis to remove wastes from the blood of patients with acute or chronic renal failure.

Reports of heart attack and death led the FDA to recall Granuflo Concentrate and Naturalyte Liquid, which are products commonly used during dialysis. These products have been shown to increase levels of sodium bicarbonate in the blood which can lead to irregular heartbeat, heart attack, stroke and death. These products are used in over 1,800 of its clinics and sold to hospitals and other dialysis clinics. Class I recalls are the most serious type of FDA product recalls and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences and death.

An internal Fresenius memo stated that Fresenius had knowledge that there was a significant increased risk of sudden cardiac arrest and death associated with the use of GranuFlo during dialysis treatments. Because of this knowledge and their decision to not inform patients of this issue, Fresenius has now found itself opened to numerous lawsuits across the nation.

Protect your rights. Get compensated for your injuries.

If you or a loved one has experienced sudden cardiac arrest or if someone has died within 72 hours of dialysis that occurred resulting from the use of Granuflo Concentrate or Naturalyte Liquid, please contact the Miller Firm LLC now.